German Validation Study of the Subjective Cognitive Decline Questionnaire (SCD-Q)

Recruiting N/A Interventional Study
Alzheimer Disease Subjective Cognitive Decline
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
50 and older
Sex
Any
Study type
Interventional
Purpose
Screening
Participants needed
300 (estimated)
Sponsor
Ludwig-Maximilians - University of Munich · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The SCD-Q (Subjective Cognitive Decline-Questionnaire) is an established instrument to quantify self-perceived cognitive decline. Both self- and informant-rated versions of the SCD-Q are available. However, the SCD-Q has not been validated in the German language yet. Hence, the investigators aim to validate the self-reported SCD-Q in a clinical sample in Germany.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Medical appointment for dementia diagnostics at the Alzheimer Therapie- und Forschungszentrum * Provision of signed, written and dated informed consent * Capacity to give informed consent Exclusion Criteria: * dementia in a very advance stage * Illiteracy
Contacts

Carolin Kurz, Dr.

+4989440055863

Psy.Alzheimerzentrum@med.uni-muenchen.de

CONTACT